Ian Tolfree is currently the CEO of TBT Pharma, serving as Principal at Emerald Development Managers LP. Ian also has experience as a Member Board of Directors at Dipole Materials and has held various leadership roles in companies such as Latella Neuromuscular Training Systems, LLC, Imogin/Tarsier Optics, and Gemstone Biotherapeutics. With a background in theoretical physics, Ian has been involved in a variety of industries including technology, healthcare, and academia.
This person is not in any offices